Form EFFECT Biodexa Pharmaceuticals
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | March 30, 2026 |
| Accession Number: | 0001214659-26-003931 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BQP Appoints NUAIR CEO Craig Marcinkowski to Board of Directors as U.S. Growth Accelerates Across Defense and Aerospace
- LACERA Pension Benefits Generate More Than $5.3 Billion in Economic Activity and Support Over 21,300 Jobs Across California
- BODYBAR PILATES CONTINUES FLORIDA EXPANSION, OPENING NEWEST STUDIO IN ROYAL PALM BEACH THIS SUMMER
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
